Gain Therapeutics elects seven directors, ratifies auditor at annual meeting

Gain Therapeutics, Inc.

All seven director nominees elected: Mack, Goldstein, Hasler, Islam, Melincoff, Nicaise, Riley; each received >13.5M votes.
Ratification of Ernst & Young AG as independent auditor for FY 2026 approved with ~25.9M for, 1.1M against.
Broker non-votes of ~11.7M shares on director elections.

item 5.07

Gain Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-077820

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.